Servo-n HFOV Study: Safety and Performance in Neonates and Infants
NCT: NCT06114992 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to evaluate the safety and performance of High-Frequency Oscillatory Ventilation (HFOV) modes of the Servo-n ventilator in neonates and infants, by using a prospective, observational, single-arm (i.e., non-controlled) and multi-center Post-Market Follow-up (PMCF) study design. HFOV treatment will be evaluated by assessing ventilation and oxygenation variables, and safety will be evaluated by documentation of device related adverse events.
Frequently Asked Questions
What is Servo-n HFOV Study: Safety and Performance in Neonates and Infants?
Servo-n HFOV Study: Safety and Performance in Neonates and Infants is a clinical trial registered under NCT06114992. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06114992?
The current status of NCT06114992 (Servo-n HFOV Study: Safety and Performance in Neonates and Infants) is: ACTIVE_NOT_RECRUITING.
When did Servo-n HFOV Study: Safety and Performance in Neonates and Infants start?
Servo-n HFOV Study: Safety and Performance in Neonates and Infants started on 2024-07-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.